-transparent.png){kind=logo}
In a continuing search for new biologically active agents derived from indolizine, 3-(2-aminoethyl)-2-methylindolizine, 3-(2-aminoethyl)-2-methyl-5,6,7,8-tetrahydroindolizine, and some mono- and di-N-substituted derivatives were prepared. Initial pharmacological screening showed that these compounds possess anti-5-hydroxytryptamine, antihistamine, antiacetylcholine, and CNS-depressant activities.
Related Publications
I Antonini, and
F Claudi, and
U Gulini, and
L Micossi, and
F Venturi
September 1977,
Journal of pharmaceutical sciences,
I Antonini, and
F Claudi, and
U Gulini, and
L Micossi, and
F Venturi
February 1977,
Journal of pharmaceutical sciences,
I Antonini, and
F Claudi, and
U Gulini, and
L Micossi, and
F Venturi
March 1957,
Journal of the American Pharmaceutical Association. American Pharmaceutical Association,
I Antonini, and
F Claudi, and
U Gulini, and
L Micossi, and
F Venturi
June 2009,
Bioorganic & medicinal chemistry letters,
I Antonini, and
F Claudi, and
U Gulini, and
L Micossi, and
F Venturi
June 1996,
Chemical & pharmaceutical bulletin,
I Antonini, and
F Claudi, and
U Gulini, and
L Micossi, and
F Venturi
January 1954,
Il Farmaco; edizione scientifica,
I Antonini, and
F Claudi, and
U Gulini, and
L Micossi, and
F Venturi
July 1968,
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
I Antonini, and
F Claudi, and
U Gulini, and
L Micossi, and
F Venturi
November 1989,
Archiv der Pharmazie,
I Antonini, and
F Claudi, and
U Gulini, and
L Micossi, and
F Venturi
January 1968,
Journal of the Chemical Society. Perkin transactions 1,
I Antonini, and
F Claudi, and
U Gulini, and
L Micossi, and
F Venturi
March 2013,
Bioorganic & medicinal chemistry letters,
